• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类固醇在耳蜗内的分布因给药方式而异:全身注射与鼓室内注射。

Steroid intracochlear distribution differs by administration method: Systemic versus intratympanic injection.

作者信息

Lee Jong Joo, Jang Jeong Hun, Choo Oak-Sung, Lim Hye Jin, Choung Yun-Hoon

机构信息

Department of Otolaryngology, Ajou University School of Medicine, Suwon, Republic of Korea.

Soree Ear Clinic, Seoul, Republic of Korea.

出版信息

Laryngoscope. 2018 Jan;128(1):189-194. doi: 10.1002/lary.26562. Epub 2017 Mar 17.

DOI:10.1002/lary.26562
PMID:28304075
Abstract

OBJECTIVE

Steroids have been widely used to treat inner-ear diseases such as sudden sensorineural hearing loss, tinnitus, and Meniere's disease. They can be given via either systemic or intratympanic (IT) injection. The purpose of the present study was to explore differences in intracochlear steroid distribution by the administration method employed (systemic vs. IT injection).

STUDY DESIGN

Animal study.

METHODS

Twenty-three Sprague-Dawley rats were given fluorescein isothiocyanate-labeled dexamethasone (FITC-DEX) three times (on successive days) via intraperitoneal (IP) or IT injection. Cochlear uptake of FITC-DEX was evaluated via immunohistochemistry and flow cytometry at 6 hours, and 3 and 7 days after the final injection.

RESULTS

FITC-DEX uptake was evident in spiral ganglion cells (SGs), the organ of Corti (OC), and the lateral walls (LWs), the basal turns of which were stained relatively prominently in both groups. Animals receiving IP injections exhibited higher FITC-DEX uptakes by the SGs and OC, whereas IT injection triggered higher-level FITC-DEX accumulation by the OC and LWs. Flow cytometry revealed that intracochlear FITC-DEX uptake by IT-injected animals was higher and more prolonged than in animals subjected to IP injections.

CONCLUSION

We thus describe differences in cochlear steroid distributions after systemic and IT injections. This finding could help our understanding of the pharmacokinetics of steroids in the cochlea.

LEVEL OF EVIDENCE

NA. Laryngoscope, 128:189-194, 2018.

摘要

目的

类固醇已被广泛用于治疗内耳疾病,如突发性感音神经性听力损失、耳鸣和梅尼埃病。它们可以通过全身给药或鼓室内(IT)注射。本研究的目的是探讨采用不同给药方法(全身给药与IT注射)时耳蜗内类固醇分布的差异。

研究设计

动物研究。

方法

23只Sprague-Dawley大鼠通过腹腔内(IP)或IT注射,连续三天给予异硫氰酸荧光素标记的地塞米松(FITC-DEX)。在最后一次注射后的6小时、3天和7天,通过免疫组织化学和流式细胞术评估耳蜗对FITC-DEX的摄取情况。

结果

FITC-DEX在螺旋神经节细胞(SGs)、柯蒂氏器(OC)和侧壁(LWs)中摄取明显,两组动物中这些结构的基底转染色相对较深。接受IP注射的动物,SGs和OC对FITC-DEX的摄取较高,而IT注射则使OC和LWs中FITC-DEX的积累水平更高。流式细胞术显示,与接受IP注射的动物相比,接受IT注射的动物耳蜗内FITC-DEX的摄取更高且持续时间更长。

结论

因此,我们描述了全身给药和IT注射后耳蜗类固醇分布的差异。这一发现有助于我们理解类固醇在耳蜗中的药代动力学。

证据水平

NA。《喉镜》,2018年,第128卷,第189 - 194页。

相似文献

1
Steroid intracochlear distribution differs by administration method: Systemic versus intratympanic injection.类固醇在耳蜗内的分布因给药方式而异:全身注射与鼓室内注射。
Laryngoscope. 2018 Jan;128(1):189-194. doi: 10.1002/lary.26562. Epub 2017 Mar 17.
2
A comparison of systemic and local dexamethasone administration: From perilymph/cochlea concentration to cochlear distribution.局部和全身地塞米松给药的比较:从外淋巴液/耳蜗浓度到耳蜗分布。
Hear Res. 2018 Dec;370:1-10. doi: 10.1016/j.heares.2018.09.002. Epub 2018 Sep 7.
3
Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents.地塞米松在内耳的药代动力学:给药途径及促渗剂应用的比较
Otolaryngol Head Neck Surg. 2000 Apr;122(4):521-8. doi: 10.1067/mhn.2000.102578.
4
Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form.鼓室内注射地塞米松:内耳分布的时间进程及其向活性形式的转化。
Otol Neurotol. 2006 Jun;27(4):564-9. doi: 10.1097/01.mao.0000194814.07674.4f.
5
Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.2次与4次鼓室内注射类固醇治疗特发性突发性感音神经性听力损失的比较
Ann Otol Rhinol Laryngol. 2018 Apr;127(4):235-240. doi: 10.1177/0003489418755406. Epub 2018 Feb 7.
6
Therapeutic Effect of Dexamethasone for Noise-induced Hearing Loss: Systemic Versus Intratympanic Injection in Mice.地塞米松对噪声性听力损失的治疗效果:小鼠全身给药与鼓室内注射对比研究
Otol Neurotol. 2015 Jun;36(5):755-62. doi: 10.1097/MAO.0000000000000759.
7
Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.全身治疗失败后鼓室内注射地塞米松治疗突发性感音神经性听力损失
Laryngoscope. 2007 Jan;117(1):3-15. doi: 10.1097/01.mlg.0000245058.11866.15.
8
Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration.鼓室内给药与全身给药时地塞米松在小鼠耳蜗中的摄取。
J Otolaryngol Head Neck Surg. 2013 Feb 27;42(1):19. doi: 10.1186/1916-0216-42-19.
9
Sound Exposure Promotes Intratympanic Drug Delivery to the Inner Ear.声暴露促进鼓室内药物向内耳传递。
Otolaryngol Head Neck Surg. 2024 Oct;171(4):1133-1139. doi: 10.1002/ohn.801. Epub 2024 Apr 30.
10
Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.鼓室内注射地塞米松治疗特发性突发性感音神经性听力损失的初步治疗
Curr Opin Otolaryngol Head Neck Surg. 2016 Oct;24(5):407-12. doi: 10.1097/MOO.0000000000000288.

引用本文的文献

1
[Role of intratympanic glucocorticoid treatment in sudden hearing loss].鼓室内糖皮质激素治疗在突发性听力损失中的作用
HNO. 2024 Apr;72(4):291-302. doi: 10.1007/s00106-024-01424-z. Epub 2024 Feb 13.
2
Evaluation of Sudden Sensory-Neural Hearing Loss Patients Treated with Systemic Steroids with Additional Intratympanic Dexamethasone Injection in Different Intervals; a Clinical Trial Study.不同间隔时间鼓膜内注射地塞米松辅助全身用类固醇治疗突发性感音神经性听力损失患者的评估;一项临床试验研究
Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):568-573. doi: 10.1007/s12070-023-03641-4. Epub 2023 Mar 15.
3
Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear.
使用可生物降解药物递送植入物向内耳控释地塞米松对突发性听力损失进行三级治疗的病例系列中的安全性和听力结果
Front Neurosci. 2022 Sep 20;16:892777. doi: 10.3389/fnins.2022.892777. eCollection 2022.
4
Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials.使用纳米颗粒和其他生物材料将治疗药物局部递送至耳蜗
Pharmaceuticals (Basel). 2022 Sep 7;15(9):1115. doi: 10.3390/ph15091115.
5
Effect of Dexamethasone Combination with Gentamicin in Chemical Labyrinthectomy on Hearing Preservation and Vertigo Control in Patients with Unilateral Meniere's Disease: A Randomized Controlled Clinical Trial.地塞米松联合庆大霉素化学性迷路切除对单侧梅尼埃病患者听力保留及眩晕控制的影响:一项随机对照临床试验
J Clin Med. 2021 Nov 27;10(23):5581. doi: 10.3390/jcm10235581.
6
Analysis of Pharmacokinetics in the Cochlea of the Inner Ear.内耳耳蜗的药代动力学分析
Front Pharmacol. 2021 May 3;12:633505. doi: 10.3389/fphar.2021.633505. eCollection 2021.
7
[New progress of IGF-1 and allosteroid injection in the treatment of sudden deafness complicated with type 2 diabetes].胰岛素样生长因子-1与别孕烯醇酮注射治疗2型糖尿病合并突发性聋的新进展
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Jun;34(6):569-572. doi: 10.13201/j.issn.2096-7993.2020.06.021.
8
Comparison of the Effects of Intratympanic Steroid Injection at Different Intervals in Sudden Sensorineural Hearing Loss.不同间隔时间鼓室内注射类固醇治疗突发性感音神经性听力损失的效果比较
J Audiol Otol. 2020 Jan;24(1):24-28. doi: 10.7874/jao.2019.00318. Epub 2019 Nov 4.
9
Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.鼓室内地塞米松与白藜芦醇治疗顺铂诱导耳毒性的疗效比较:一项实验研究。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3287-3293. doi: 10.1007/s00405-019-05635-x. Epub 2019 Sep 17.
10
Advances and Challenges in Pharmaceutical Therapies to Prevent and Repair Cochlear Injuries From Noise.预防和修复噪声性耳蜗损伤的药物治疗进展与挑战
Front Cell Neurosci. 2019 Jun 26;13:285. doi: 10.3389/fncel.2019.00285. eCollection 2019.